- Record: found
- Abstract: found
- Article: not found
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
Jackson T Wright
1 ,
George Bakris ,
Tom Greene ,
Larry Y Agodoa ,
Lawrence J Appel ,
Jeanne Charleston ,
DeAnna Cheek ,
Janice G Douglas-Baltimore ,
Jennifer Gassman ,
Richard Glassock ,
Lee Hebert ,
Kenneth Jamerson ,
Julia Lewis ,
Robert A Phillips ,
Robert D Toto ,
John P Middleton ,
Stephen G Rostand
Nov 20 2002
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Hypertension is a leading cause of end-stage renal disease (ESRD) in the United States, with no known treatment to prevent progressive declines leading to ESRD.